サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1427685

臨床試験におけるAIの世界市場レポート 2024

AI In Clinical Trials Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.90円
臨床試験におけるAIの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

臨床試験におけるAIの市場規模は、今後数年間で急激に成長すると予想されています。2028年には41.5%の年間複合成長率（CAGR）で267億7,000万米ドルに成長すると予想されます。臨床試験におけるAIの予測期間で予想される成長は、現実世界のデータの統合、AIを利用した患者募集プロセス、AIを使用したバイオマーカーの特定、AI主導の方法論による試験設計の最適化、そして継続監視技術の採用など、さまざまな要因に起因すると考えられています。予測期間中に予想される主要な動向には、フェデレーテッドラーニングアプローチの使用、アダプティブトライアルにおけるAIの統合、AIを活用した結果予測、AI主導の医薬品開発イニシアチブ、医薬品再利用の取り組みにおけるAIの応用などが含まれます。これらの動向は集合的に臨床試験におけるAIの進化する情勢に貢献し、臨床試験プロセスのさまざまな側面の最適化における進歩と革新を示しています。

予想される慢性疾患や感染症の急増により、近い将来、臨床試験におけるAI市場の発展が促進されると予想されます。慢性疾患は、3か月以上続く病気を特徴とし、時間の経過とともに徐々に悪化します。臨床試験における人工知能の統合は、慢性疾患の治療に合わせたさまざまな薬の開発に役立つことが証明されています。たとえば、米国に本拠を置く機関である国立医学図書館は、2023年1月の時点で、米国内で少なくとも1つの慢性疾患を患っている50歳以上の人口が99.5%という驚異的な増加を示し、2020年の7,152万2,000人から、2050年までには1億4,266万人に急増すると予測しています。したがって、慢性疾患や感染症の蔓延は、臨床試験におけるAI市場の成長を促進する触媒として機能します。

急成長する製薬分野は、臨床試験領域におけるAI実装の拡大の促進力となると予想されています。この分野には、政府機関と民間機関による医薬品の発見、開発、製造が含まれます。製薬業界の臨床試験における人工知能の統合は、効率を高め、医薬品開発プロセスを加速し、意思決定プロトコルを洗練するのに役立ちます。AIテクノロジーは、広範なデータセットを細心の注意を払って分析し、患者の反応を予測し、適切な治験参加者を特定し、治験の枠組みを最適化することで、よりコスト効率が高く合理化された臨床試験を実現します。たとえば、2023年6月時点の欧州医薬品産業協会連合（EFPIA）の統計によると、欧州の医薬品生産全体は2022年に3,842億米ドル（3,400億ユーロ）に達し、3,662億6,700万米ドル（3,239億5,000万ユーロ）から約4.95%増加しました。その結果、製薬業界の拡大は臨床試験分野におけるAI統合の成長の促進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 臨床試験における世界のAI市場促進要因と制約要因
    • 市場の促進要因
    • 市場の抑制要因
  • 世界の臨床試験におけるAIの市場規模実績と成長、2018年～2023年
  • 世界の臨床試験におけるAIの市場規模と成長予測、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の臨床試験におけるAI市場、製品別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • ソフトウェア
  • サービス
  • 世界の臨床試験におけるAI市場、プロセス別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • トライアルデザイン
  • 患者の選択
  • サイト選択
  • 患者のモニタリング
  • 世界の臨床試験におけるAI市場、テクノロジー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 機械学習
  • ディープラーニング
  • 教師あり学習
  • その他の技術
  • 世界の臨床試験におけるAI市場、用途別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 腫瘍学
  • 神経疾患と状態
  • 心血管疾患
  • 代謝性疾患
  • 感染症
  • 免疫疾患
  • その他の用途
  • 世界の臨床試験におけるAI市場、エンドユーザー別セグメンテーション、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 製薬会社とバイオテクノロジー企業
  • 受託調査機関
  • その他のエンドユーザー

第7章 地域と国の分析

  • 世界の臨床試験におけるAI市場、地域別、実績と予測、2018年～2023年、2023年～2028年、2033年
  • 世界の臨床試験におけるAI市場、国別、実績と予測、2018年～2023年、2023年～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 臨床試験におけるAI市場の競合情勢
  • 臨床試験におけるAI市場の企業プロファイル
    • Intel
    • The International Business Machines Corporation（IBM）
    • Koninklijke Philips NV
    • ConcertAI
    • Saama Technologies LLC

第31章 その他の大手と革新的な企業

  • Samaa Technologies
  • Owkin Inc.
  • Numerate
  • Neuroute
  • AiCure
  • Ardigen
  • Unlearn AI
  • PathAI
  • Exscentia
  • Aitia Infotech Pvt Ltd.
  • Euretos
  • VeriSIM Life
  • Envisagenics
  • NURITAs
  • BioSymetrics

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r13529

AI in clinical trials involves the application of artificial intelligence (AI) technologies and techniques in the planning, design, execution, and analysis of clinical trials. Clinical trials are rigorous research studies that assess the safety and effectiveness of medical interventions, such as new drugs, medical devices, or treatment protocols, in human subjects.

The primary offerings for AI in clinical trials include software and services. AI in clinical trial services encompasses the investigation and generation of insights from past and current clinical trials. Various processes, including trial design, patient selection, site selection, and patient monitoring, leverage technologies such as machine learning, deep learning, supervised learning, and other machine learning technologies. These applications span across various medical fields such as oncology, neurological diseases, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases. The end-users of AI in clinical trials include pharmaceuticals and biotechnology companies, contract research organizations, and others.

The AI in clinical trials market research report is one of a series of new reports from The Business Research Company that provides AI in clinical trials market statistics, including AI in clinical trials industry global market size, regional shares, competitors with AI in clinical trials market share, detailed AI in clinical trials market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in clinical trials industry. This AI in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ai in clinical trials market size has grown exponentially in recent years. It will grow from $4.74 billion in 2023 to $6.69 billion in 2024 at a compound annual growth rate (CAGR) of 41.1%. The growth observed in the historic period for AI in clinical trials can be attributed to several factors, including the accumulation of data in healthcare, advancements in computing power, support for AI from regulatory bodies such as the FDA, the rise of wearable devices facilitating data collection, and the early development of AI algorithms tailored for clinical trial applications. These factors collectively contributed to the increased adoption and success of AI technologies in optimizing various aspects of clinical trials during the historical period.

The ai in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $26.77 billion in 2028 at a compound annual growth rate (CAGR) of 41.5%. The anticipated growth in the forecast period for AI in clinical trials can be attributed to various factors, including the integration of real-world data, AI-powered patient recruitment processes, identification of biomarkers using AI, optimization of trial designs through AI-driven methodologies, and the adoption of continuous monitoring technology. Key trends expected in the forecast period encompass the use of federated learning approaches, the integration of AI in adaptive trials, AI-supported outcome prediction, AI-driven drug development initiatives, and the application of AI in drug repurposing efforts. These trends collectively contribute to the evolving landscape of AI in clinical trials, showcasing advancements and innovations in optimizing various aspects of the clinical trial process.

The anticipated surge in chronic and infectious diseases is poised to drive the advancement of the AI in clinical trials market in the foreseeable future. Chronic ailments, characterized by illnesses lasting three months or longer, progressively worsen over time. The integration of artificial intelligence in clinical trials proves instrumental in the development of diverse drugs tailored to treat chronic diseases. For example, as of January 2023, the National Library of Medicine, a US-based agency, forecasts a staggering 99.5% rise in individuals aged 50 and above grappling with at least one chronic condition in the US, soaring from 71.522 million in 2020 to an estimated 142.66 million by 2050. Hence, the escalating prevalence of chronic and infectious diseases serves as a catalyst propelling the AI in clinical trials market growth.

The burgeoning pharmaceutical sector is anticipated to be a driving force behind the expansion of AI implementation in the clinical trials domain. This sector encompasses the discovery, development, and manufacturing of drugs and medications by governmental and private entities alike. Artificial intelligence integration within clinical trials within the pharmaceutical industry serves to heighten efficiency, hasten drug development processes, and refine decision-making protocols. AI technologies meticulously analyze extensive datasets, forecast patient responses, identify suitable trial participants, and optimize trial frameworks, resulting in more cost-efficient and streamlined clinical trials. For instance, statistics from the European Federation of Pharmaceutical Industries and Associations (EFPIA) as of June 2023 indicate that the overall pharmaceutical production in Europe reached $384,200 million (€340,000 million) in 2022, marking an approximate 4.95% increase from $366,267 million (€323,950 million) in 2021. Consequently, the escalating expansion of the pharmaceutical industry is a driving force behind the growth of AI integration in the clinical trials sector.

The surge in technological advancements stands as a pivotal trend gaining traction within the AI in clinical trials market. Entities entrenched in this market segment are actively embracing novel technologies to fortify their standing. An illustrative instance is the introduction, in February 2023, by Lantern Pharma, a US-based clinical-stage oncology company, of its distinctive RADR artificial intelligence (AI) and machine learning (ML) platform. This innovation aims to revolutionize the cost, pace, and duration associated with discovering and developing oncology medications. The RADR advancements primarily focus on pioneering AI and ML methodologies tailored to craft antibody-drug conjugates (ADCs). These ADCs, comprised of precisely targeted antibodies linked to potent anti-tumor small molecules, offer promising treatment avenues for cancer.

Major players within the AI in clinical trials sector are embracing a strategic partnership approach to introduce enhanced research tools and workflow efficiencies, leading to augmented timelines and improved patient recruitment. Strategic partnerships signify a collaborative process wherein companies capitalize on each other's strengths and resources to achieve mutual advantages and success. An exemplification of this strategy occurred in February 2023 when a US-based pharmaceutical commercial company partnered with Haystack Health, a US-based software development enterprise. Their partnership aims to harness the potential of AI and Natural Language Processing (NLP) to expedite clinical trials, enhance patient recruitment, and diminish the screen failure rate, which incurs considerable time and financial costs. This collaboration intends to leverage clinical AI and pre-screening services to achieve these goals effectively.

In October 2022, Beckman Coulter Diagnostics, a clinical diagnostics company based in the United States, successfully acquired StoCastic LLC for an undisclosed amount. This strategic acquisition is poised to enhance evidence-based Clinical Decision Support (CDS) capabilities and leverage Beckman Coulter Diagnostics' biomarkers to generate improved decision-support insights. The integration of StoCastic's artificial intelligence expertise into Beckman Coulter Diagnostics' offerings aims to empower clinicians to make more informed decisions quickly, ultimately contributing to enhanced patient outcomes. StoCastic LLC, based in the United States, is an artificial intelligence company specializing in the development of healthcare software.

Major companies operating in the ai in clinical trials market report are Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI, Saama Technologies LLC, Samaa Technologies, Owkin Inc., Numerate, Neuroute, AiCure, Ardigen, Unlearn AI, PathAI, Exscentia, Aitia Infotech Pvt Ltd., Euretos, VeriSIM Life, Envisagenics, Nuritas, BioSymetrics, BioAge Labs Inc, Trials.Ai, Pharmaseal, Caylx, IQVIA

North America was the largest region in the AI in clinical trials market in 2023. The regions covered in the ai in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ai in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The AI in clinical trials market consists of revenues earned by entities by providing AI software solutions and platforms designed to assist in various aspects of clinical trials, such as trial design, patient recruitment, data collection, monitoring, and analysis, data analytics and insights, predictive modeling and simulation, regulatory compliance, and safety monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in clinical trials also includes sales of computer vision technology, cognitive computing, and machine translation technologies which are used in providing clinical trials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Clinical Trials Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Offering: Software; Services
  • 2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring
  • 3) By Technology: Machine Learning; Deep Learning; Supervised Learning; Other Technologies
  • 4) By Application: Oncology; Neurological Diseases And Condition; Cardiovascular Diseases; Metabolic Diseases; Infectious Diseases; Immunology diseases; Other Applications
  • 5) By End-User: Pharmaceuticals And Biotechnology Companies; Contract Research Organizations; Other End-Users
  • Companies Mentioned: Intel; The International Business Machines Corporation (IBM); Koninklijke Philips N.V.; ConcertAI; Saama Technologies LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Clinical Trials Market Characteristics

3. AI In Clinical Trials Market Trends And Strategies

4. AI In Clinical Trials Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global AI In Clinical Trials Market Size and Growth

  • 5.1. Global AI In Clinical Trials Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global AI In Clinical Trials Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global AI In Clinical Trials Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. AI In Clinical Trials Market Segmentation

  • 6.1. Global AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software
  • Services
  • 6.2. Global AI In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Trial Design
  • Patient Selection
  • Site Selection
  • Patient Monitoring
  • 6.3. Global AI In Clinical Trials Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Other Technologies
  • 6.4. Global AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Neurological Diseases And Condition
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Immunology diseases
  • Other Applications
  • 6.5. Global AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pharmaceuticals And Biotechnology Companies
  • Contract Research Organizations
  • Other End-Users

7. AI In Clinical Trials Market Regional And Country Analysis

  • 7.1. Global AI In Clinical Trials Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global AI In Clinical Trials Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific AI In Clinical Trials Market

  • 8.1. Asia-Pacific AI In Clinical Trials Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China AI In Clinical Trials Market

  • 9.1. China AI In Clinical Trials Market Overview
  • 9.2. China AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India AI In Clinical Trials Market

  • 10.1. India AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan AI In Clinical Trials Market

  • 11.1. Japan AI In Clinical Trials Market Overview
  • 11.2. Japan AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia AI In Clinical Trials Market

  • 12.1. Australia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia AI In Clinical Trials Market

  • 13.1. Indonesia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea AI In Clinical Trials Market

  • 14.1. South Korea AI In Clinical Trials Market Overview
  • 14.2. South Korea AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe AI In Clinical Trials Market

  • 15.1. Western Europe AI In Clinical Trials Market Overview
  • 15.2. Western Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK AI In Clinical Trials Market

  • 16.1. UK AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany AI In Clinical Trials Market

  • 17.1. Germany AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France AI In Clinical Trials Market

  • 18.1. France AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy AI In Clinical Trials Market

  • 19.1. Italy AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain AI In Clinical Trials Market

  • 20.1. Spain AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe AI In Clinical Trials Market

  • 21.1. Eastern Europe AI In Clinical Trials Market Overview
  • 21.2. Eastern Europe AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia AI In Clinical Trials Market

  • 22.1. Russia AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America AI In Clinical Trials Market

  • 23.1. North America AI In Clinical Trials Market Overview
  • 23.2. North America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA AI In Clinical Trials Market

  • 24.1. USA AI In Clinical Trials Market Overview
  • 24.2. USA AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada AI In Clinical Trials Market

  • 25.1. Canada AI In Clinical Trials Market Overview
  • 25.2. Canada AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America AI In Clinical Trials Market

  • 26.1. South America AI In Clinical Trials Market Overview
  • 26.2. South America AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil AI In Clinical Trials Market

  • 27.1. Brazil AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East AI In Clinical Trials Market

  • 28.1. Middle East AI In Clinical Trials Market Overview
  • 28.2. Middle East AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa AI In Clinical Trials Market

  • 29.1. Africa AI In Clinical Trials Market Overview
  • 29.2. Africa AI In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa AI In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa AI In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. AI In Clinical Trials Market Competitive Landscape And Company Profiles

  • 30.1. AI In Clinical Trials Market Competitive Landscape
  • 30.2. AI In Clinical Trials Market Company Profiles
    • 30.2.1. Intel
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. The International Business Machines Corporation (IBM)
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Koninklijke Philips N.V.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. ConcertAI
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Saama Technologies LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. AI In Clinical Trials Market Other Major And Innovative Companies

  • 31.1. Samaa Technologies
  • 31.2. Owkin Inc.
  • 31.3. Numerate
  • 31.4. Neuroute
  • 31.5. AiCure
  • 31.6. Ardigen
  • 31.7. Unlearn AI
  • 31.8. PathAI
  • 31.9. Exscentia
  • 31.10. Aitia Infotech Pvt Ltd.
  • 31.11. Euretos
  • 31.12. VeriSIM Life
  • 31.13. Envisagenics
  • 31.14. NURITAs
  • 31.15. BioSymetrics

32. Global AI In Clinical Trials Market Competitive Benchmarking

33. Global AI In Clinical Trials Market Competitive Dashboard

34. Key Mergers And Acquisitions In The AI In Clinical Trials Market

35. AI In Clinical Trials Market Future Outlook and Potential Analysis

  • 35.1 AI In Clinical Trials Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 AI In Clinical Trials Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 AI In Clinical Trials Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer